THAP6
THAP domain-containing protein 6
Also known as: MGC30052, THAP6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBB0
- Gene
- THAP6
- Ensembl
- ENSG00000174796
- Chromosome
- 4
- Canonical length
- 222 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Centrosome
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Predicted to be involved in endothelial cell proliferation and regulation of DNA-templated transcription. Located in microtubule cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>Q8TBB0|THAP6
1 MVKCCSAIGC ASRCLPNSKL KGLTFHVFPT DENIKRKWVL AMKRLDVNAA GIWEPKKGDV
61 LCSRHFKKTD FDRSAPNIKL KPGVIPSIFD SPYHLQGKRE KLHCRKNFTL KTVPATNYNH
121 HLVGASSCIE EFQSQFIFEH SYSVMDSPKK LKHKLDHVIG ELEDTKESLR NVLDREKRFQ
181 KSLRKTIREL KDECLISQET ANRLDTFCWD CCQESIEQDY ISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against THAP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- testis: 22 nTPM
- retina: 20 nTPM
- skin: 16 nTPM
- endometrium: 15 nTPM
- lymph node: 15 nTPM
- skeletal muscle: 15 nTPM
Single-cell type
- early spermatids: 175 nCPM
- cardiomyocytes: 127 nCPM
- late primary spermatocytes: 105 nCPM
- tuft cells: 69 nCPM
- oligodendrocytes: 61 nCPM
- bergmann glia: 61 nCPM
Immune cell
- neutrophil: 18 nTPM
- basophil: 17 nTPM
- T-reg: 14 nTPM
- eosinophil: 13 nTPM
- MAIT T-cell: 13 nTPM
- naive CD4 T-cell: 12 nTPM
Brain region
- white matter: 65 nTPM
- cerebellum: 53 nTPM
- basal ganglia: 48 nTPM
- medulla oblongata: 48 nTPM
- hypothalamus: 47 nTPM
- pons: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THAP6 as an antibody target. Whether an autoantibody or antibody against THAP6 could matter depends on whether native THAP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THAP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label THAP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...